999 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
PFE Pfizer, Inc. $43.01 $252.13B N/A
Article Searches
Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More http://www.zacks.com/stock/news/411198/drug-biotech-stock-q1-earnings-on-may-9-ions-xlrn-more?cid=CS-ZC-FT-411198 May 08, 2019 - Five drug/biotech stocks are scheduled to release their first-quarter results on May 9. Let's take a look at how these companies are poised ahead of their earnings release.
Array BioPharma (ARRY) Q3 Earnings and Sales Beat Estimates http://www.zacks.com/stock/news/411124/array-biopharma-arry-q3-earnings-and-sales-beat-estimates?cid=CS-ZC-FT-411124 May 08, 2019 - Array BioPharma's (ARRY) top and bottom lines beat estimates in the third quarter of fiscal 2019. Momentum in uptake of Braftovi-Mektovi combination therapy continues.
What's in the Cards for Nektar (NKTR) This Earnings Season? http://www.zacks.com/stock/news/410186/whats-in-the-cards-for-nektar-nktr-this-earnings-season?cid=CS-ZC-FT-410186 May 07, 2019 - The focus will be on Nektar Therapeutics' (NKTR) pipeline progress when the company reports first-quarter results.
The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo http://www.zacks.com/stock/news/409269/the-zacks-analyst-blog-highlights-merck-pfizer-abbvie-sanofi-and-glaxo?cid=CS-ZC-FT-409269 May 06, 2019 - The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins http://www.zacks.com/stock/news/409211/the-zacks-analyst-blog-highlights-pfizer-intel-hca-healthcare-xilinx-and-cummins?cid=CS-ZC-FT-409211 May 06, 2019 - The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins
5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term https://www.fool.com/investing/2019/05/05/5-reasons-why-pfizer-is-a-great-stock-to-buy-and-h.aspx?source=iedfolrf0000001 May 05, 2019 - A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.
Top Stock Reports for Pfizer, Intel & HCA Healthcare http://www.zacks.com/research-daily/408482/top-stock-reports-for-pfizer-intel-hca-healthcare?cid=CS-ZC-FT-408482 May 03, 2019 - Top Stock Reports for Pfizer, Intel & HCA Healthcare
Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod http://www.zacks.com/stock/news/408311/pharma-stock-roundup-mrk-lly-pfe-report-q1-earnings-sny-abbv-drugs-get-eu-nod?cid=CS-ZC-FT-408311 May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
Dow 30 Stock Roundup: AAPL, PFE, MRK, MCD Earnings Impress http://www.zacks.com/stock/news/408282/dow-30-stock-roundup-aapl-pfe-mrk-mcd-earnings-impress?cid=CS-ZC-FT-408282 May 03, 2019 - The index traversed a mixed week, buoyed by encouraging earnings numbers and dragged lower by comments from the Fed Chair.
Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1 http://www.zacks.com/stock/news/407891/exelixis-exel-earnings-revenues-beat-estimates-in-q1?cid=CS-ZC-FT-407891 May 02, 2019 - Exelixis's (EXEL) earnings and revenues beat expectations in the first quarter on strong sales of Cabometyx.

Pages: 123456789...100

<<<Page 4>